[Construction of a recombinant stable Ba/F3 cell strain containing Tpr-Met]

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Nov;28(11):1151-3.
[Article in Chinese]

Abstract

Aim: To construct a stable cell strain encoding tumor-associated fused gene which expresses oncoprotein Tpr-Met.

Methods: We transfected Tpr-Met vector into Ba/F3 cells and screened the cell strain stably expressing Tpr-Met. The interleukin 3 (IL-3) independent proliferation of the cells was measured using the MTS assay. The expression of Tpr-Met, the activity of downstream signal transduction pathway and SU11274-induced inhibition of the signal pathway were investigated by Western blotting.

Results: We obtained a Ba/F3 cell strain stably expressing Tpr-Met. The cells presented IL-3 independent proliferation, suggesting a malignant transformation of the cell line. In Tpr-Met transformed Ba/F3 cells, the phosphorylation of Met and ERK were enhanced; however, specific c-Met inhibitor SU11274 suppressed the cell proliferation and c-Met phosphorylation.

Conclusion: Tpr-Met transformed Ba/F3 strain has been successfully constructed.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Proliferation / drug effects
  • Indoles / pharmacology
  • Interleukin-3 / pharmacology
  • Mice
  • Oncogene Protein tpr-met / genetics*
  • Phosphorylation
  • Piperazines / pharmacology
  • Signal Transduction
  • Sulfonamides / pharmacology
  • Transfection*

Substances

  • ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)
  • Indoles
  • Interleukin-3
  • Oncogene Protein tpr-met
  • Piperazines
  • Sulfonamides